Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, Bristol Myers Squibb, and AstraZeneca. As North ...

According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 14 Billion by 2035 at ...

The Global Prescription Drugs Market is valued at USD 1240.33 Billion in 2024 and is projected to reach a value of USD 2755 ...

How are advanced diagnostics benefitting patients? Our recent webinar discussed next-gen molecular analysis in precision ...

According to Future Market Insight, the global genitourinary prosthetics market is likely to reach USD 924.8 million by 2033, registering a CAGR of 4.8 %. This is a considerable increase from its ...

Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune ...

A screening program enabled timely screenings for cardiotoxicity and allowed patients to receive optimal cancer treatment.

The decision to choose systemic adjuvant therapy warrants careful discussion on its benefits and risks,” researchers wrote.

Barriers contributing to underreporting of fatigue also include belief that symptom is sign disease is progressing and attempt to be a “good patient.” ...

The prevalence of autism spectrum disorder (ASD) was 32.2 per 1,000 children aged 8 years across 16 sites in the United ...

HealthDay News — The US Food and Drug Administration (FDA) has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for adults with unresectable or metastatic hepatocellular ...